Immutep hits 50% enrollment in Phase 3 trial
Immutep (ASX:IMM) announced a significant operational breakthrough in its global TACTI-004 (KEYNOTE-F91) Phase 3 clinical trial.
Every story in this section, newest first — page 250 of 294.
Immutep (ASX:IMM) announced a significant operational breakthrough in its global TACTI-004 (KEYNOTE-F91) Phase 3 clinical trial.
MGX Resources (ASX:MGX) has completed its acquisition of a 50% interest in the Central Tanami Gold Project joint venture.
PWR Holdings (ASX:PWH) appointed Robert Shore as its new CFO, effective April 21.
Australian biotech firm Terragen (ASX:TGH) announced binding commitments for a $7 million equity raising.
Neuren Pharmaceuticals (ASX:NEU) has commenced dosing in its "Koala" Phase 3 clinical trial.
Healthscope's lenders are poised to endorse a rescue plan that will transform the nation's second-largest private hospital operator into a not-for-profit entity.
HMC Capital (ASX:HMC) has partnered with KKR to secure a $603 million investment for its Energy Transition Platform, accelerating Australia’s shift to net-zero.
Charter Hall Retail REIT (ASX:CQR) reported strong H1 FY26 results with $75.6 million in operating earnings and 3.4% growth.
REA Group (ASX:REA) reported strong H1 FY26 results with $916m revenue and record audience engagement, driven by a 14% yield growth and strategic AI expansion.
News Corp. (ASX:NWS) reported a strong second quarter for fiscal 2026, headlined by a 6% revenue increase to US$2.36 billion.
The global mining landscape has been jolted after Rio Tinto (ASX:RIO) abandoned merger talks with Swiss rival Glencore.
New PBO analysis revealed the CGT discount will cost the budget $247 billion over 10 years, sparking calls for urgent reform to address housing inequality.
Great Western Exploration (ASX:GTE) has cleared the path for an aggressive exploration blitz across its Yerrida North Copper-Gold Project in Western Australia.
The Australian and New Zealand dollars demonstrated resilience on Feb. 5’s trading sessions, buoyed by widening yield differentials.
Epsilon Healthcare (ASX:EPN) partnered with Puro New Zealand in a multi-year deal to manufacture organic medicinal cannabis.
European Lithium (ASX:EUR) has strengthened its liquidity position by completing the sale of 2.5 million ordinary shares in Critical Metals Corp (NASDAQ:CRML).
Apollo Minerals (ASX:AON) has secured a significant financial boost as Tribeca Investment Partners committed to a $2.8 million strategic placement.
Australia's goods trade surplus widened to $3.4 billion in December 2025, fueled by a resurgence in commodity exports and a dip in national imports.
Regal Partners (ASX:RPL) has greenlit an on-market share buy-back program, signaling strong confidence in its financial trajectory.
Resolute Mining (ASX:RSG) has cleared its final major regulatory hurdle in West Africa, securing a mining permit for the Doropo Gold Project.
Celsius Resources (ASX:CLA) said the Mines and Geosciences Bureau has approved the first renewal of Exploration Permit No. 011-2023-CAR for the Botilao Porphyry Copper-Gold prospect.
FirstWave Cloud Technology (ASX:FCT) entered into a high-tech collaboration with the University of the Sunshine Coast and Australia's national science agency, CSIRO.
Australian critical minerals producer Volt Resources (ASX:VRC) has accelerated the development of its flagship Bunyu Graphite Project.
Origin Energy (ASX:ORG) has declined to trigger its taxpayer-funded safety-net agreement for the Eraring coal power station for the 2027 fiscal year.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy